Business Segments EKF Diagnostics Holdings plc
Equities
EKF
GB0031509804
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.65 GBX | +0.35% | +2.69% | -9.48% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Development, Manufacture and Supply of Products and Services | 44.92M | 65.26M | 81.84M | 66.64M | 52.61M | |||||
Total Assets | 87.13M | 101M | 115M | 89.29M | 80.85M | |||||
Interest Expense | -58K | -76K | -68K | -102K | -75K | |||||
Income Tax Expense | 1.59M | 3.97M | 5.28M | 634K | -600K | |||||
CAPEX | -2.38M | -2.64M | -5.65M | -5.83M | -6.6M | |||||
EBT | 5.52M | 15.36M | 21.44M | -8.94M | 2.13M | |||||
Gross Profit | 23.73M | 37.42M | 39.37M | 24.04M | 23.86M | |||||
D&A | 3.93M | 4.36M | 5.23M | 5.62M | 5.06M | |||||
Operating Income | 5.78M | 16.9M | 21.75M | -8.97M | 2.08M | |||||
Net Income | 3.68M | 11.11M | 15.85M | -10.1M | 2.35M |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Germany | 23.09M | 25.64M | 39.66M | 30.38M | 27.12M | |||||
Total Assets | 39.62M | 43.09M | 38.06M | 44.61M | 43.4M | |||||
Interest Expense | - | -26K | - | - | - | |||||
Income Tax Expense | 677K | 820K | 2.81M | 790K | - | |||||
D&A | 2.82M | 2.43M | 2.28M | 2.41M | 2.09M | |||||
CAPEX | -1.61M | -1.46M | -1.39M | -1.71M | -1.31M | |||||
Net Income | 4.29M | 4.94M | 5.91M | 2.97M | - | |||||
Operating Income | 4.98M | 5.79M | 8.75M | 3.79M | 3.81M | |||||
EBITDA | 7.44M | 7.34M | 11.48M | 8.09M | 6.46M | |||||
United States of America | 25.43M | 39.46M | 38.97M | 37.22M | 26.13M | |||||
Total Assets | 30.11M | 44.36M | 65.54M | 63M | 57.67M | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 449K | 3.5M | 2.4M | -644K | - | |||||
D&A | 1.55M | 1.63M | 2.32M | 3.76M | 2.99M | |||||
CAPEX | -617K | -910K | -11.54M | -6.1M | -6.04M | |||||
Net Income | 6.03M | 14.98M | 7.98M | -10.04M | - | |||||
Operating Income | 6.47M | 18.46M | 10.41M | -10.68M | 1.78M | |||||
EBITDA | 8.02M | 20.09M | 12.74M | 8.31M | 6.85M | |||||
Russia | 3.06M | 2.9M | 3.29M | 4.2M | 3.57M | |||||
Total Assets | 1.75M | 1.61M | 1.78M | 3.24M | 2.98M | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 164K | 171K | 193K | 348K | - | |||||
D&A | 21K | 25K | 57K | 21K | 37K | |||||
CAPEX | -17K | -54K | -17K | -84K | -56K | |||||
Net Income | 634K | 676K | 769K | 1.31M | - | |||||
Operating Income | 761K | 808K | 924K | 1.54M | 1.06M | |||||
EBITDA | 782K | 833K | 981K | 1.56M | 1.09M | |||||
Net Income | - | - | - | - | - | |||||
United Kingdom | - | - | 8.51M | 1.43M | 816K | |||||
Total Assets | - | - | 34.74M | 13.9M | 10.1M | |||||
Income Tax Expense | - | - | -124K | 140K | - | |||||
D&A | - | - | 1.23M | 466K | 352K | |||||
CAPEX | - | - | -2.13M | -472K | -8K | |||||
Net Income | - | - | 1.49M | -3.81M | - | |||||
Operating Income | - | - | 1.66M | -3.62M | -4.56M | |||||
EBITDA | - | - | 1.29M | -3.06M | -4.02M | |||||
Poland | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
Ireland | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
Other | - | 4.43M | - | - | - | |||||
Total Assets | 41.85M | 40.6M | - | - | - | |||||
Interest Expense | - | -1.57M | - | - | - | |||||
Income Tax Expense | 296K | -517K | - | - | - | |||||
D&A | 56K | 522K | - | - | - | |||||
CAPEX | -130K | -741K | - | - | - | |||||
Net Income | -7.02M | -9.21M | - | - | - | |||||
Operating Income | -6.42M | -8.16M | - | - | - | |||||
EBITDA | -4.23M | -2.75M | - | - | - | |||||
Inter Segment | -6.67M | -7.17M | -8.6M | -6.6M | -5.03M | |||||
Total Assets | -26.2M | -28.39M | -24.99M | -35.45M | -33.3M |
- Stock Market
- Equities
- EKF Stock
- Financials EKF Diagnostics Holdings plc
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition